Articles tagged with 'clinical studies' | BIOTRONIK

BIOTRONIK - Archive (clinical studies)

2021
18
March
2021
| 09:32 Europe/Amsterdam
Due to the high rates of mortality and morbidity in heart failure patients, it is essential that heart failure cases are continuously and proactively monitored. ...
Read more
15
March
2021
| 14:42 Europe/Amsterdam
BIOTRONIK’s ultrathin-strut stent, Orsiro®*, demonstrated superiority over Xience DES for target lesion failure (TLF) at 24 months, according to new follow-up data from the BIOSTEMI trial.1The latest results were presented by Prof. Thomas Pilgrim, In...
Read more
23
February
2021
| 09:10 Europe/Amsterdam
One thing our ongoing global pandemic hasn’t put on hold is the need to act early when providing emergency cardiovascular care. Heart attacks and strokes are still happening, even as it feels the world around us has slowed down. Heart researchers hav...
Read more
2020
01
September
2020
| 16:12 Europe/Amsterdam
A new study1 presented at this year’s European Society of Cardiology (ESC) Congress today shows that BIOTRONIK’s exclusive Closed Loop Stimulation (CLS) helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. ...
Read more
01
September
2020
| 07:00 Europe/Amsterdam
Cardiologists balancing increasing workload pressures and time demands in their clinics, have from today access to a new injectable cardiac monitor (ICM). BIOMONITOR IIIm is equipped with a unique algorithm that significantly reduces false positive a...
Read more
22
July
2020
| 17:54 Europe/Amsterdam
The true toll COVID-19 has taken on public health around the world is difficult to pinpoint at the moment - but it’s much higher than the official death toll from the virus itself. ...
Read more
08
July
2020
| 16:59 Europe/Amsterdam
This year will long be remembered as the year the COVID-19 pandemic overwhelmed healthcare systems around the world. From postponing elective surgeries to reassigning entire hospital units to coronavirus response, hospitals have gone to unprecedented...
Read more